---
schema_version: "secwatch.filing_event.v1"
accession: "0001387131-23-009113"
form_type: "8-K"
ticker: null
cik: "0000887247"
company_name: "DMK PHARMACEUTICALS Corp"
filed_at: "2023-07-31T23:59:59+00:00"
generated_at: "2026-06-12T22:40:04.691229+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Adamis Pharmaceuticals closes sale of Conway, AR property for $2M to FarmaKeio Pharmacy Network

## Summary
- Sold building, real property, equipment, and IP for $2M cash before estimated fees of ~$232,700.
- Buyer is unaffiliated third party FarmaKeio Pharmacy Network, LLC.
- Property formerly used by discontinued compounding pharmacy business.

## SEC filing metadata
- accession: 0001387131-23-009113
- form_type: 8-K
- cik: 0000887247
- company_name: DMK PHARMACEUTICALS Corp
- filed_at: 2023-07-31T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 2.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/887247/000138713123009113/0001387131-23-009113-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/887247/000138713123009113/admp-8k_072523.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001387131-23-009113
- JSON: https://secwatch.observer/filing/0001387131-23-009113.json
- Plain text: https://secwatch.observer/filing/0001387131-23-009113.txt

## Key facts
- M&A Transactions
  DMK PHARMACEUTICALS Corp completed a disposition involving FarmaKeio Pharmacy Network, LLC for $2,000,000, before commissions, fees and closing costs estimated at approximately $232,700 (closed 2023-07-25).
  - Action: disposition
  - Counterparty: FarmaKeio Pharmacy Network, LLC
  - Consideration: $2,000,000, before commissions, fees and closing costs estimated at approximately $232,700
  - Closing: 2023-07-25
  source text: we sold the building, real property, personal property, equipment and related assets. The total aggregate consideration for the sale of the real property and other assets was $2,000,000, before commissions, fees and closing costs estimated at approximately $232,700. The Agreement includes a number customary provisions addressing matters such as title and title
  evidence_url: https://www.sec.gov/Archives/edgar/data/887247/000138713123009113/0001387131-23-009113-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.